Serving leading biopharmaceutical companies globally:

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Dr Reddys Labs Ltd Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for DR REDDYS LABS LTD, and what generic and branded alternatives to DR REDDYS LABS LTD drugs are available?

DR REDDYS LABS LTD has one hundred and eighteen approved drugs.

There are ten tentative approvals on DR REDDYS LABS LTD drugs.

Summary for Dr Reddys Labs Ltd

US Patents:	0
Tradenames:	92
Ingredients:	87
NDAs:	118

Drugs and US Patents for Dr Reddys Labs Ltd

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dr Reddys Labs Ltd	ATORVASTATIN CALCIUM	atorvastatin calcium	TABLET;ORAL	091650-002	Jul 17, 2012	AB	RX	No	No		Start Trial				Start Trial
Dr Reddys Labs Ltd	OLANZAPINE	olanzapine	TABLET, ORALLY DISINTEGRATING;ORAL	076534-001	Oct 24, 2011	AB	RX	No	No		Start Trial				Start Trial
Dr Reddys Labs Ltd	CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE	candesartan cilexetil; hydrochlorothiazide	TABLET;ORAL	202965-003	Jun 3, 2013	AB	RX	No	No		Start Trial				Start Trial
Dr Reddys Labs Ltd	ATOMOXETINE HYDROCHLORIDE	atomoxetine hydrochloride	CAPSULE;ORAL	090609-001	Feb 23, 2018	AB	RX	No	No		Start Trial				Start Trial
Dr Reddys Labs Ltd	IRBESARTAN AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; irbesartan	TABLET;ORAL	203500-002	Sep 27, 2012	AB	RX	No	No		Start Trial				Start Trial
Dr Reddys Labs Ltd	ONDANSETRON HYDROCHLORIDE	ondansetron hydrochloride	TABLET;ORAL	076183-004	Dec 26, 2006		RX	No	No		Start Trial				Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for DR REDDYS LABS LTD drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt

Boehringer Ingelheim

Harvard Business School

Johnson and Johnson

McKesson

Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.